|
Characteristic
|
Baseline
|
After treatment
|
MD (95% CI)
|
P value
|
|---|
|
SBP, mean (SD) mmHg
|
144.69 (9.29)
|
140.48 (9.77)
|
4.36 (1.97, 6.74)
|
< 0.001
|
|
DBP, mean (SD) mmHg
|
88.61 (8.15)
|
86.31 (8.02)
|
2.16 (0.45, 3.87)
|
< 0.05
|
|
dSBP, mean (SD) mmHg
|
147.32 (9.88)
|
143.02 (10.47)
|
4.48 (1.92, 7.04)
|
< 0.01
|
|
dDBP, mean (SD) mmHg
|
90.30 (8.49)
|
88.10.23 (8.24)
|
2.12 (0.38, 3.87)
|
< 0.05
|
|
nSBP, mean (SD) mmHg
|
136.20 (12.21)
|
132.59 (12.90)
|
3.77 (0.91, 6.64)
|
< 0.05
|
|
nDBP, mean (SD) mmHg
|
82.83 (8.78)
|
80.60 (9.64)
|
2.10 (-0.01, 4.21)
|
0.051
|
- Blood pressure changes after six-week EA treatment. MD mean difference, dSBP/dDBP daytime systolic/diastolic blood pressure, nSBP/nDBP nighttime systolic/diastolic blood pressure. All data were analyzed by paired-sample T test, P < 0.05 were considered statistically significant
